EPIGENONCO - Key Persons

DR. Michael K. O'Brien - CEO

Job Titles:
  • Chief Executive Officer
  • Member of the Scientific Leadership Board
Dr. O'Brien is an innovative biopharmaceutical executive who has previously led large pharmaceutical process R&D organizations and matrixed new technology development groups at Sanofi, Wyeth, Pfizer. He is also the Founder of NGT BioPharma Consultants, a company focused on the many aspects of biopharmaceutical drug development, from late-stage Discovery through Clinical Development, Registration, and Commercialization.

Jean-Pierre Issa - President

Job Titles:
  • Chief Scientific Officer
  • Member of the Scientific Leadership Board
  • President
  • Physician - Scientist
Dr. Issa is an internationally renowned physician-scientist and recognized as one of the pioneers of epigenetic therapy. Dr. Issa has over 25 years of experience in the field of epigenetics and cancer research, over 350 peer-reviewed publications, and is the recipient of numerous NIH grants.

Patricia Kropf

Job Titles:
  • Chief Medical Officer
  • Member of the Scientific Leadership Board
Dr. Kropf is a board-certified hematologist who treats Dr. Kropf is a board-certified hematologist who treats patients with myeloid neoplasms, including Acute Myeloid Leukemia and Myelodysplastic Syndromes.